CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
CytoSorbents regains compliance with Nasdaq minimum bid price requirement…
0,807€
Echtzeit-Aktienkurs Cytosorbents Corp.
Bid:
Ask:
Nachrichten zur Cytosorbents Corp. Aktie
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"…
CytoSorbents Secures $20 Million Credit Facility
$20 million credit facility provides CytoSorbents with important non-dilutive capital to support its regulatory and commercialization objectives…
CytoSorbents reports regulatory approval of CytoSorb in Taiwan
…